• AMN Healthcare posted Q2 2026 revenue of $673.2 million, up 2% year over year, as GAAP net income swung to $21.2 million.
• GAAP diluted EPS was $0.53; adjusted diluted EPS rose to $0.77 from $0.30 a year earlier, while adjusted EBITDA increased 26% to $73.4 million.
• Gross margin widened 0.8 percentage points to 30.6%, helped by reserve releases and billing true-ups tied to earlier labor disruption events.
• Nurse and Allied Solutions revenue rose 11% to $422 million, while Technology and Workforce Solutions fell 15% to $87 million.
• For Q3 2026, AMN forecast revenue of $640 million-$655 million, with adjusted EBITDA margin seen at 6.5%-7%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AMN Healthcare Services Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.